awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33553099-1A8123AA-E709-4FF3-9726-34B61132A1CD
Q33553099-1A8123AA-E709-4FF3-9726-34B61132A1CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33553099-1A8123AA-E709-4FF3-9726-34B61132A1CD
Hepatitis C for addiction professionals.
P2860
Q33553099-1A8123AA-E709-4FF3-9726-34B61132A1CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33553099-1A8123AA-E709-4FF3-9726-34B61132A1CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b265d5cb9b389e2bc6b3a50f9b974f462e478bca
P2860
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.